deltatrials
Terminated OBSERVATIONAL NCT01790269

Monitoring Natural Killer Cells in Multiple Sclerosis Patients Treated With Fingolimod

Monitoring Natural Killer Cells in Multiple Sclerosis Patients Treated With Fingolimod: a Monocentric, Prospective, One Year, Baseline-to-treatment, Open-label Single Group Pilot Trial

Sponsor: Charite University, Berlin, Germany

Conditions Relapsing-Remitting Multiple Sclerosis
Updated 10 times since 2017 Last updated: Jul 28, 2021 Started: Sep 30, 2013 Primary completion: Aug 31, 2018 Completion: Aug 31, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This trial was terminated. No reason was provided.

Other terminated trials from Charite University, Berlin, Germany

See all terminations from Charite University, Berlin, Germany

Other Relapsing-Remitting Multiple Sclerosis trials with similar outcome

Browse all Relapsing-Remitting Multiple Sclerosis trials

A observational or N/A phase clinical study on Relapsing-Remitting Multiple Sclerosis, this trial is terminated or withdrawn. The trial is conducted by Charite University, Berlin, Germany and has accumulated 10 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Jan 2018 · 12 months · monthly snapshotRecruiting~Jan 2018 – ~Apr 2018 · 3 months · monthly snapshotActive Not Recruiting~Apr 2018 – ~Jun 2018 · 2 months · monthly snapshotActive Not Recruiting~Jun 2018 – ~Dec 2018 · 6 months · monthly snapshotActive Not Recruiting~Dec 2018 – ~May 2020 · 17 months · monthly snapshotTerminated~May 2020 – ~Jan 2021 · 8 months · monthly snapshotTerminated~Jan 2021 – ~Sep 2021 · 8 months · monthly snapshotTerminated~Sep 2021 – ~Jul 2024 · 34 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 24 months · monthly snapshotTerminated

Change History

10 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated

  3. Sep 2021 — Jul 2024 [monthly]

    Terminated

  4. Jan 2021 — Sep 2021 [monthly]

    Terminated

  5. May 2020 — Jan 2021 [monthly]

    Terminated

▶ Show 5 earlier versions

  1. Dec 2018 — May 2020 [monthly]

    Terminated

    Status: Active Not Recruiting → Terminated

  2. Jun 2018 — Dec 2018 [monthly]

    Active Not Recruiting

  3. Apr 2018 — Jun 2018 [monthly]

    Active Not Recruiting

    Phase: NA → None

  4. Jan 2018 — Apr 2018 [monthly]

    Active Not Recruiting NA

    Status: Recruiting → Active Not Recruiting

  5. Jan 2017 — Jan 2018 [monthly]

    Recruiting NA

    First recorded

Sep 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Charite University, Berlin, Germany
  • Dr. Carmen Infante-Duarte
Data source: Charite University, Berlin, Germany

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations